Yanling Zhao Selected Research

gingerol

11/2020	Metabolomics coupled with integrated approaches reveal the therapeutic effects of higenamine combined with [6]-gingerol on doxorubicin-induced chronic heart failure in rats.
1/2020	Therapeutic effects of higenamine combined with [6]-gingerol on chronic heart failure induced by doxorubicin via ameliorating mitochondrial function.
7/2019	Protective effects of higenamine combined with [6]-gingerol against doxorubicin-induced mitochondrial dysfunction and toxicity in H9c2 cells and potential mechanisms.
1/2019	Corrigendum to "Protective effects of higenamine combined with [6]-gingerol against doxorubicin-induced mitochondrial dysfunction and toxicity in H9c2 cells and potential mechanisms" [Biomed. Pharmacother. 115 (2019) 108881].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yanling Zhao Research Topics

Disease

35	Neoplasms (Cancer) 01/2024 - 06/2007
23	Inflammation (Inflammations) 11/2023 - 06/2007
17	Neuroblastoma 11/2022 - 10/2013
15	Cholestasis 04/2024 - 03/2012
12	Liver Cirrhosis (Hepatic Cirrhosis) 10/2023 - 11/2014
11	Heart Failure 01/2021 - 08/2017
9	Atrophic Gastritis 03/2022 - 01/2020
8	Liver Diseases (Liver Disease) 10/2023 - 12/2014
8	Fibrosis (Cirrhosis) 01/2022 - 11/2014
5	Non-alcoholic Fatty Liver Disease 10/2023 - 01/2020
5	Breast Neoplasms (Breast Cancer) 01/2019 - 06/2008
4	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 03/2024 - 09/2021
4	Vomiting 01/2024 - 01/2020
4	Stomach Ulcer (Gastric Ulcer) 01/2024 - 01/2020
4	Gastritis 09/2023 - 01/2015
4	Ulcerative Colitis 06/2022 - 01/2021
4	Body Weight (Weight, Body) 07/2021 - 08/2013
4	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 07/2016
4	Infections 01/2021 - 11/2017
4	Hepatitis 01/2020 - 03/2012
3	Cough 08/2022 - 01/2021
3	Respiratory Sounds (Crackle) 08/2022 - 01/2021
3	Carcinogenesis 01/2022 - 11/2017
3	Chronic Hepatitis B 01/2021 - 01/2015
2	Dyspepsia (Indigestion) 01/2024 - 01/2023
2	Bradycardia 01/2024 - 01/2021
2	Acute Kidney Injury (Acute Renal Failure) 12/2023 - 11/2020
2	COVID-19 11/2023 - 01/2020
2	Bicuspid Aortic Valve Disease 07/2023 - 01/2022
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2023 - 01/2018
2	Hemorrhage 01/2023 - 11/2020
2	Intrahepatic Cholestasis of Pregnancy 11/2022 - 01/2021
2	Chemical and Drug Induced Liver Injury 11/2022 - 12/2015
2	Pneumonia (Pneumonitis) 10/2022 - 08/2022
2	Nausea 10/2022 - 01/2020
2	Colitis 01/2022 - 01/2022
2	Alzheimer Disease (Alzheimer's Disease) 08/2021 - 01/2014
2	Necrosis 08/2021 - 05/2017
2	Insulin Resistance 01/2021 - 01/2020
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 07/2015
2	Cardiac Arrhythmias (Arrythmia) 01/2021 - 06/2019
2	Reperfusion Injury 01/2021 - 08/2019
2	Lung Neoplasms (Lung Cancer) 01/2021 - 06/2008

Drug/Important Bio-Agent (IBA)

18	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2020 - 10/2013
15	Therapeutic UsesIBA 10/2021 - 01/2016
11	Bile Acids and Salts (Bile Acids)IBA 01/2023 - 08/2013
10	peoniflorinIBA 11/2022 - 03/2012
10	Proteins (Proteins, Gene)FDA Link 07/2022 - 01/2014
8	zuojinIBA 03/2022 - 01/2015
6	Anti-Bacterial Agents (Antibiotics)IBA 08/2022 - 01/2017
6	BerberineIBA 06/2022 - 05/2020
6	Proteasome InhibitorsIBA 01/2019 - 01/2016
5	1-Naphthylisothiocyanate (1 Naphthylisothiocyanate)IBA 04/2024 - 03/2012
5	Biomarkers (Surrogate Marker)IBA 01/2024 - 04/2015
5	Interleukin-6 (Interleukin 6)IBA 08/2021 - 01/2020
5	higenamine (norcoclaurine)IBA 01/2021 - 01/2019
4	Long Noncoding RNAIBA 07/2022 - 12/2017
4	GlycosidesIBA 01/2021 - 01/2020
4	Sirtuin 1IBA 01/2021 - 08/2017
4	gingerolIBA 11/2020 - 01/2019
4	Phosphotransferases (Kinase)IBA 10/2019 - 01/2017
4	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2019 - 01/2016
3	Ethanol (Ethyl Alcohol)IBA 01/2024 - 01/2020
3	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 08/2019
3	Alanine Transaminase (SGPT)IBA 01/2021 - 01/2014
3	yinchenhaoIBA 01/2021 - 06/2015
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 01/2014
3	Caspase 3 (Caspase-3)IBA 01/2021 - 11/2017
3	Sevoflurane (Ultane)FDA LinkGeneric 01/2020 - 08/2019
3	ginger extractIBA 06/2019 - 08/2017
3	fuzi drug herbalIBA 12/2017 - 05/2014
3	BilirubinIBA 04/2015 - 08/2013
2	qingwen baiduIBA 11/2023 - 01/2020
2	LipopolysaccharidesIBA 05/2023 - 11/2022
2	SolutionsIBA 01/2023 - 01/2022
2	AlbuminsIBA 01/2023 - 01/2022
2	Heme Oxygenase-1IBA 01/2023 - 01/2021
2	tanreqingIBA 08/2022 - 01/2021
2	InflammasomesIBA 07/2022 - 01/2022
2	huanglian-jie-du decoctionIBA 01/2022 - 01/2021
2	ChromatinIBA 10/2021 - 07/2015
2	rutecarpineIBA 06/2021 - 01/2020
2	Methylnitronitrosoguanidine (MNNG)IBA 05/2021 - 01/2021
2	NF-kappa B (NF-kB)IBA 01/2021 - 05/2017
2	Epidermal Growth Factor (EGF)IBA 01/2021 - 01/2017
2	Monoterpenes (Monoterpenoids)IBA 01/2021 - 01/2020
2	kusheninIBA 01/2021 - 01/2015
2	Nonprescription Drugs (Patent Medicines)IBA 01/2021 - 12/2018
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 08/2011
2	AntipyreticsIBA 01/2021 - 01/2020
2	entecavir FDA Link 01/2021 - 01/2020
2	AlkaloidsIBA 12/2020 - 06/2020
2	palmatineIBA 09/2020 - 01/2020
2	AcidsIBA 06/2020 - 06/2008

Therapy/Procedure

17	Therapeutics 03/2024 - 01/2015
14	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2024 - 01/2017
13	Drug Therapy (Chemotherapy) 01/2021 - 06/2008
3	Aftercare (After-Treatment) 01/2023 - 06/2008
2	Length of Stay 01/2024 - 11/2020
2	Bariatric Surgery 01/2023 - 02/2016